Methods of Cancer Diagnosis, Therapy, and Prognosis: Liver Cancer (Hardback)

Edité par Springer-Verlag New York Inc., 2009
ISBN 10: 1402098030 / ISBN 13: 9781402098031
Ancien(s) ou d'occasion / Hardback / Quantité : 0
Disponible auprès d'autres vendeurs
Afficher tous les  exemplaires de ce livre

Au sujet du livre

Ce livre n'est malheureusement plus disponible. AbeBooks dispose cependant de millions de livres. Ci-dessous, nous vous proposons une liste de livres pouvant correspondre à votre recherche.

Description :

Language: English Brand New Book. This volume presents a detailed survey of imaging, multidetector-row computed t- various methodologies related to diagno- ography, helical computed tomography, sis, therapy, and prognosis of liver cancer, ultrasonography, and power Doppler ult- including colorectal liver metastases and sound, for the prognosis and assessment of biliary tract carcinomas, while the already liver cancer treatment (including HCC) and published Volumes 1, 2, 3, and 4 detail liver metastases from colorectal cancer are similar aspects of breast, lung, prostate, discussed in detail, as is the use of radiof- gastrointestinal, and colorectal cancer, quency ablation in hepatic tumors. respectively. Approximately 50 of colorectal cancer Surgical resection is the standard therapy (CRC) patients develop liver metastases for resectable liver disease, resulting in during the course of their disease, and 5-year overall survival rates of 20-40 . more than 50 of patients who die of CRC One the other hand, the median overall have liver metastases at autopsy. Regional survival of patients with unresectable liver lymph node (RLN) involvement in patients metastases does not exceed 18-20 months, with colorectal liver metastases is one with a 5-year survival rate approaching of the worst prognostic factors. Recent zero. In other words, there is virtually no studies indicate that for these patients, long-term survival. Both resectable and combined liver resection and pedicular unresectable liver cancers are discussed lymphadenectomy can be recommended, in this volume. The method of selecting when RLN metastases respond to p- patients for resection of hepatic colorectal operative chemotherapy. N° de réf. du libraire

A propos du livre :

Book ratings provided by GoodReads) :
0 note moyenne
(0 avis)

Synopsis :

This fifth volume of the series, Methods of Cancer Diagnosis, Therapy, and Prognosis, discusses in detail the diagnosis, treatment, and prognosis of Liver Cancer. Both standard and emerging therapies for this cancer, written by expert oncologists/pathologists in this field, are included.

This fully illustrated volume:

  • Is divided into 7 sections: Applications of Imaging, Resectable Liver Cancer, Unresectable Liver Cancer, Hepatocellular Cancer, Liver Colorectal Metastasis, Biliary Cancer, and Splenic Cancer.
  • Discusses imaging modalities for diagnosis, treatment assessment, and prognosis.
  • Includes descriptions of radial magnetic resonance imaging, helical computed tomography, magnetic resonance imaging, FDG-PET, contrast-enhanced sonography, multidetector-row computed tomography, and single photon emission computed tomography.
  • Presents imaging methods for localized fibrous tumors of the liver, abdominal neoplasms, cholangiocarcinoma, gall bladder carcinoma, hepatic cellular carcinoma, extrahepatic disease, intrahepatic disease, focal liver lesions, biliary cystic tumors, extra hepatic bile duct carcinoma, and splenic metastases.
  • Highlights methods for treatment of hepatocellular carcinoma (HCC) with thalidomide and transarterial treatment of hepatic malignancies.
  • Discusses postoperative interferon alpha treatment of patients with HCC.
  • Details the methods of immunohistochemistry, tissue microarray, and proteomic analysis for diagnosis and prognosis.

The technological advances presented in this volume are expected to expedite new discoveries and their translation to clinical practice. The field of oncology will benefit the most from these advanced methods, as a combination of therapies and personalized medicine will improve early detection of liver cancer and other cancer types.

Professor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.

Synopsis: This volume presents a detailed survey of imaging, multidetector-row computed t- various methodologies related to diagno- ography, helical computed tomography, sis, therapy, and prognosis of liver cancer, ultrasonography, and power Doppler ult- including colorectal liver metastases and sound, for the prognosis and assessment of biliary tract carcinomas, while the already liver cancer treatment (including HCC) and published Volumes 1, 2, 3, and 4 detail liver metastases from colorectal cancer are similar aspects of breast, lung, prostate, discussed in detail, as is the use of radiof- gastrointestinal, and colorectal cancer, quency ablation in hepatic tumors. respectively. Approximately 50% of colorectal cancer Surgical resection is the standard therapy (CRC) patients develop liver metastases for resectable liver disease, resulting in during the course of their disease, and 5-year overall survival rates of 20?40%. more than 50% of patients who die of CRC One the other hand, the median overall have liver metastases at autopsy. Regional survival of patients with unresectable liver lymph node (RLN) involvement in patients metastases does not exceed 18?20 months, with colorectal liver metastases is one with a 5-year survival rate approaching of the worst prognostic factors. Recent zero. In other words, there is virtually no studies indicate that for these patients, long-term survival. Both resectable and combined liver resection and pedicular unresectable liver cancers are discussed lymphadenectomy can be recommended, in this volume. The method of selecting when RLN metastases respond to p- patients for resection of hepatic colorectal operative chemotherapy.

Les informations fournies dans la section « A propos du livre » peuvent faire référence à une autre édition de ce titre.

Détails bibliographiques

Titre : Methods of Cancer Diagnosis, Therapy, and ...
Éditeur : Springer-Verlag New York Inc.
Date d'édition : 2009
Reliure : Hardback
Etat du livre : New

Meilleurs résultats de recherche sur AbeBooks

1.

ISBN 10 : 1402098030 ISBN 13 : 9781402098031
Ancien(s) ou d'occasion Quantité : 1
Vendeur
Castle Rock
(Pittsford, NY, Etats-Unis)
Evaluation vendeur
[?]

Description du livre État : Like New. Book Condition: Like New. N° de réf. du libraire 97814020980312.0

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter D'occasion
EUR 42,47
Autre devise

Ajouter au panier

Frais de port : EUR 3,71
Vers Etats-Unis
Destinations, frais et délais

2.

Edité par Springer (2009)
ISBN 10 : 1402098030 ISBN 13 : 9781402098031
Neuf(s) Couverture rigide Quantité : 2
Vendeur
Murray Media
(North Miami Beach, FL, Etats-Unis)
Evaluation vendeur
[?]

Description du livre Springer, 2009. Hardcover. État : New. N° de réf. du libraire P111402098030

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 73,04
Autre devise

Ajouter au panier

Frais de port : EUR 2,78
Vers Etats-Unis
Destinations, frais et délais

3.

Edité par Springer (2009)
ISBN 10 : 1402098030 ISBN 13 : 9781402098031
Neuf(s) Couverture rigide Quantité : 1
Vendeur
Irish Booksellers
(Rumford, ME, Etats-Unis)
Evaluation vendeur
[?]

Description du livre Springer, 2009. Hardcover. État : New. book. N° de réf. du libraire 1402098030

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 192,46
Autre devise

Ajouter au panier

Frais de port : Gratuit
Vers Etats-Unis
Destinations, frais et délais

4.

M. A. Hayat (Editor)
Edité par Springer (2009)
ISBN 10 : 1402098030 ISBN 13 : 9781402098031
Neuf(s) Couverture rigide Quantité : 1
impression à la demande
Vendeur
Ergodebooks
(RICHMOND, TX, Etats-Unis)
Evaluation vendeur
[?]

Description du livre Springer, 2009. Hardcover. État : New. 2009. This item is printed on demand. N° de réf. du libraire DADAX1402098030

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 278,22
Autre devise

Ajouter au panier

Frais de port : EUR 3,71
Vers Etats-Unis
Destinations, frais et délais

5.

Edité par Springer-Verlag New York Inc., United States (2009)
ISBN 10 : 1402098030 ISBN 13 : 9781402098031
Neuf(s) Couverture rigide Quantité : 1
Vendeur
The Book Depository US
(London, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre Springer-Verlag New York Inc., United States, 2009. Hardback. État : New. 262 x 200 mm. Language: English . Brand New Book. This volume presents a detailed survey of imaging, multidetector-row computed t- various methodologies related to diagno- ography, helical computed tomography, sis, therapy, and prognosis of liver cancer, ultrasonography, and power Doppler ult- including colorectal liver metastases and sound, for the prognosis and assessment of biliary tract carcinomas, while the already liver cancer treatment (including HCC) and published Volumes 1, 2, 3, and 4 detail liver metastases from colorectal cancer are similar aspects of breast, lung, prostate, discussed in detail, as is the use of radiof- gastrointestinal, and colorectal cancer, quency ablation in hepatic tumors. respectively. Approximately 50 of colorectal cancer Surgical resection is the standard therapy (CRC) patients develop liver metastases for resectable liver disease, resulting in during the course of their disease, and 5-year overall survival rates of 20-40 . more than 50 of patients who die of CRC One the other hand, the median overall have liver metastases at autopsy. Regional survival of patients with unresectable liver lymph node (RLN) involvement in patients metastases does not exceed 18-20 months, with colorectal liver metastases is one with a 5-year survival rate approaching of the worst prognostic factors. Recent zero. In other words, there is virtually no studies indicate that for these patients, long-term survival. Both resectable and combined liver resection and pedicular unresectable liver cancers are discussed lymphadenectomy can be recommended, in this volume. The method of selecting when RLN metastases respond to p- patients for resection of hepatic colorectal operative chemotherapy. N° de réf. du libraire LIB9781402098031

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 334,81
Autre devise

Ajouter au panier

Frais de port : Gratuit
De Royaume-Uni vers Etats-Unis
Destinations, frais et délais

6.

Edité par Springer-Verlag New York Inc., United States (2009)
ISBN 10 : 1402098030 ISBN 13 : 9781402098031
Neuf(s) Couverture rigide Quantité : 1
Vendeur
The Book Depository
(London, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre Springer-Verlag New York Inc., United States, 2009. Hardback. État : New. 262 x 200 mm. Language: English . Brand New Book. This volume presents a detailed survey of imaging, multidetector-row computed t- various methodologies related to diagno- ography, helical computed tomography, sis, therapy, and prognosis of liver cancer, ultrasonography, and power Doppler ult- including colorectal liver metastases and sound, for the prognosis and assessment of biliary tract carcinomas, while the already liver cancer treatment (including HCC) and published Volumes 1, 2, 3, and 4 detail liver metastases from colorectal cancer are similar aspects of breast, lung, prostate, discussed in detail, as is the use of radiof- gastrointestinal, and colorectal cancer, quency ablation in hepatic tumors. respectively. Approximately 50 of colorectal cancer Surgical resection is the standard therapy (CRC) patients develop liver metastases for resectable liver disease, resulting in during the course of their disease, and 5-year overall survival rates of 20-40 . more than 50 of patients who die of CRC One the other hand, the median overall have liver metastases at autopsy. Regional survival of patients with unresectable liver lymph node (RLN) involvement in patients metastases does not exceed 18-20 months, with colorectal liver metastases is one with a 5-year survival rate approaching of the worst prognostic factors. Recent zero. In other words, there is virtually no studies indicate that for these patients, long-term survival. Both resectable and combined liver resection and pedicular unresectable liver cancers are discussed lymphadenectomy can be recommended, in this volume. The method of selecting when RLN metastases respond to p- patients for resection of hepatic colorectal operative chemotherapy. N° de réf. du libraire LIB9781402098031

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 335,48
Autre devise

Ajouter au panier

Frais de port : Gratuit
De Royaume-Uni vers Etats-Unis
Destinations, frais et délais

7.

Hayat, M. A. (Editor)
Edité par Springer Verlag (2009)
ISBN 10 : 1402098030 ISBN 13 : 9781402098031
Neuf(s) Couverture rigide Quantité : 1
Vendeur
Revaluation Books
(Exeter, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre Springer Verlag, 2009. Hardcover. État : Brand New. 1st edition. 514 pages. 10.75x8.25x1.00 inches. In Stock. N° de réf. du libraire __1402098030

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 344,80
Autre devise

Ajouter au panier

Frais de port : EUR 6,94
De Royaume-Uni vers Etats-Unis
Destinations, frais et délais

8.

Editor-M. A. Hayat
Edité par Springer (2009)
ISBN 10 : 1402098030 ISBN 13 : 9781402098031
Ancien(s) ou d'occasion Couverture rigide Quantité : 1
impression à la demande
Vendeur
Ergodebooks
(RICHMOND, TX, Etats-Unis)
Evaluation vendeur
[?]

Description du livre Springer, 2009. Hardcover. État : Used: Very Good. This item is printed on demand. N° de réf. du libraire SONG1402098030

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter D'occasion
EUR 349,42
Autre devise

Ajouter au panier

Frais de port : EUR 3,71
Vers Etats-Unis
Destinations, frais et délais

9.

M. A. HAYAT
Edité par Springer (2009)
ISBN 10 : 1402098030 ISBN 13 : 9781402098031
Neuf(s) Couverture rigide Quantité : 1
Vendeur
Herb Tandree Philosophy Books
(Stroud, GLOS, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre Springer, 2009. Hardback. État : NEW. 9781402098031 This listing is a new book, a title currently in-print which we order directly and immediately from the publisher. N° de réf. du libraire HTANDREE0293239

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 379,27
Autre devise

Ajouter au panier

Frais de port : EUR 9,25
De Royaume-Uni vers Etats-Unis
Destinations, frais et délais

10.

Hayat, M. A. (EDT)
Edité par Springer-Verlag New York Inc. 2009-04-23, New York, NY (2009)
ISBN 10 : 1402098030 ISBN 13 : 9781402098031
Neuf(s) Couverture rigide Quantité : 1
Vendeur
Blackwell's
(Oxford, OX, Royaume-Uni)
Evaluation vendeur
[?]

Description du livre Springer-Verlag New York Inc. 2009-04-23, New York, NY, 2009. hardback. État : New. N° de réf. du libraire 9781402098031

Plus d'informations sur ce vendeur | Poser une question au libraire

Acheter neuf
EUR 397,78
Autre devise

Ajouter au panier

Frais de port : EUR 5,20
De Royaume-Uni vers Etats-Unis
Destinations, frais et délais

9 autres exemplaires de ce livre sont disponibles

Afficher tous les résultats pour ce livre